[New milestones in the therapy of chronic heart failure with beta blockers].
Garlichs
C
C
Medizinische Klinik II mit Poliklinik Universitätsklinik Erlangen-Nürnberg.
Daniel
W G
WG
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy; D000077261:Carvedilol; D018849:Controlled Clinical Trials as Topic; D004311:Double-Blind Method; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D010919:Placebos; D011379:Prognosis; D011412:Propanolamines / Q000627:therapeutic use; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002227:Carbazoles; D010919:Placebos; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol; D017298:Bisoprolol